INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES


Дәйексөз келтіру

Толық мәтін

Аннотация

The article is concerned with modern methods of insulin administration; main advantages of continuous subcutaneous insulin infusion (CSII) therapy over regimen of repeated injections of the hormone are discussed. Different options for calculation of basal and bolus insulin doses before administration of CSII are presented. The results of clinical studies proving the effectiveness of insulin pump therapy are presented, in particular the elimination of dawn phenomenon, reduction of glycated hemoglobin level, reduction of demand for insulin and circadian blood glucose levels, decrease of frequency of hypoglycemia. The performance of combined system consisting of pumps and blood glucose meter, allowing to improve the compensation of diabetes, is described. It is emphasized that ongoing contact between patients using insulin pump and physician has a great importance for achieving good diabetes compensation.

Әдебиет тізімі

  1. Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. М., 2009.
  2. Bode BW, Steed RD, Davidson P. Reduction in severe hypoglycaemia with long-term continuous subcutaneous insulin infusion in type 1 diabetes. Diabetes Care 1996;19:324-27.
  3. Bruttomesso D, Crazzolara D, Maran A, et al. Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 2008;25(3):326-32.
  4. Diabetes Control and Complications Trial Research Group: Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr 1994;125(2);177-88.
  5. Garg SK, Schwartz S, Edelman SV. Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type1 diabetes. Diabetes Care 2004;27:734-38.
  6. Insulin pump treatment in children and adolescents with type 1 diabetes:experiences of the german working group for insulin pump treatment in pediatric patients Postgraduate Medicine 2010;122(3):98-105.
  7. Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1Diabetes.The RealTrend study. Diabetes Care 2009;32(12):2245-50.
  8. Pickup JC, Keen H, Parsons JA. Alberti KGMM. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1978;1:204-07.
  9. Rabbone I, Scaramuzza A, Bobboi A, et al. Insulin pump therapy management in very young children with type 1 diabetes using continuous subcutaneous insulin infusion. Diabetes Technol Ther 2009;11(11):707-09.
  10. Raccah D, Veronique S, Yves R, et al. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the realtrend study. Diabetes Care 2009;32(12):2245-50.
  11. The DCCT Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin - dependent diabetes mellitus. N Engl J Med 1993;329;977-86.
  12. Youssef MK, Gaballa F, Gaballa MR. Nephrol Dial Transplant 2011;26 (1):28-35.
  13. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R. Insulin pump therapy. Diabetes Care 2003;26(4);1079-87.
  14. Wood JR, Moreland EC, Volkening LK, et al. Durability of insulin pump use in pediatric patiens with type 1 diabetes Diabetes Care 2006;29(11):2355-60.

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>